B152 First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) vs. VAD as Induction Treatment Prior to High-dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)
Sonneveld, P, Eljarari, L, Salwender, H, Zweegman, S, Vellenga, E, Van Der Holt, B, Schmidt-Wolf, IGH, Bertsch, U, Schubert, J, Blau, IW, Jie, GSK, Beverloo, B, Jauch, A, Hose, D, Schaafsma, R, KersteVolume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70667-9
Date:
February, 2009
File:
PDF, 116 KB
english, 2009
File converter
More search results
More benefits 
